Press Release

Wockhardt LimitedWOCKPHARMA · Filed with the exchange

Wockhardt received U.S.

FDA approval for ZAYNICH™, a novel intravenous antibiotic for complicated urinary tract infections.

This marks a historic milestone as the first New Chemical Entity fully developed by an Indian pharma company to receive FDA approval.

No comments yet. Be the first.

More from Wockhardt Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.